Anacor Pharmaceuticals Announces the installation of a state of matter 2 Trial of AN2728 ... SunHerald.com AN2728 and AN2898 are boron-based small-molecule compounds which stamp down the activity of phosphodiesterase-4 (PDE-4), thereby reducing the manufacture of a reach of pro-inflammatory cytokines that are content to be related with psoriasis and atopic ... and more » Link To Article
No comments:
Post a Comment